Redmile Group’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-119
Closed -$64K 66
2014
Q4
$64K Buy
+119
New +$64K 0.01% 54
2014
Q3
Sell
-48
Closed -$65K 64
2014
Q2
$65K Hold
48
0.01% 46
2014
Q1
$66K Sell
48
-119
-71% -$164K 0.01% 55
2013
Q4
$166K Buy
+167
New +$166K 0.02% 54